The Latest Breaking News from WAVE Life Sciences

Roche Bets Up to $1.16 Billion on Rona's Obesity Drug That Aims to Cut Fat but Spare Muscle

Roche licensed Rona's experimental ALK7 obesity drug in a deal worth up to $1.16 billion. No human data are out yet. What it means for weight loss.

Medical Daily · Oct 15

Wave Life Sciences Crashes Deep into Oversold Territory as Obesity Drug Data Disappoints. Should You Buy the Dip?

Wave Life Sciences stock sinks as Phase 1 data for obesity drug disappoints investors. But Oppenheimer still recommends loading up on WVE shares today.

Barchart · Mar 27

Golden Cross Alert: 3 Stocks With Major Upside Potential

Three stocks flashing a golden cross—Sun Communities, Darling Ingredients, and Wave Life Sciences—may offer strong upside potential heading into 2026

MarketBeat · Dec 10, 2025

Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?

Wave Life Sciences Ltd. (NASDAQ:WVE) stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.

Benzinga · Sep 3, 2025

Bruce Willis’ wife Emma shares sweet family photos as she gives update on dementia research work

‘Our family will continue to keep the faith and never lose hope,’ she wrote on Instagram

The Independent UK · May 30, 2023

Bruce Willis’s wife shares update after actor’s dementia diagnosis

The ‘Die Hard’ actor’s family announced he had been diagnosed with frontotemporal dementia earlier this year

The Independent UK · May 27, 2023

Insiders Buy More Than $21M Of 3 Penny Stocks

U.S. stocks traded slightly higher on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Benzinga · Jun 22, 2022

WAVE Life Sciences's Return On Capital Employed Insights

WAVE Life Sciences (NASDAQ:WVE) brought in sales totaling $1.75 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 8.71%, resulting in a loss of $37.81 million.

Benzinga · Jun 17, 2022

Recap: WAVE Life Sciences Q1 Earnings

  WAVE Life Sciences (NASDAQ:WVE) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 12, 2022

WAVE Life Sciences Earnings Preview

WAVE Life Sciences (NASDAQ:WVE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that WAVE Life Sciences will report an earnings per share (EPS) of $-0.55.

Benzinga · May 11, 2022